PortfoliosLab logoPortfoliosLab logo
PAA vs. AVDL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PAA vs. AVDL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Plains All American Pipeline, L.P. (PAA) and Avadel Pharmaceuticals plc (AVDL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


PAA

1D
0.88%
1M
4.97%
YTD
32.09%
6M
35.41%
1Y
42.03%
3Y*
29.12%
5Y*
22.64%
10Y*
5.94%

AVDL

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PAA vs. AVDL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PAA
Plains All American Pipeline, L.P.
32.09%14.30%21.38%39.18%35.79%22.24%-50.79%-2.28%2.31%-31.34%
AVDL
Avadel Pharmaceuticals plc
0.42%105.04%-25.57%97.21%-11.39%20.96%-11.52%192.64%-68.54%-21.08%

Correlation

The correlation between PAA and AVDL is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Nov 18, 1998

0.12

Fundamentals

Market Cap

PAA:

$16.10B

AVDL:

$2.19B

EPS

PAA:

$2.19

AVDL:

-$0.00

PS Ratio

PAA:

0.36

AVDL:

8.72

PB Ratio

PAA:

1.26

AVDL:

22.31

Total Revenue (TTM)

PAA:

$45.25B

AVDL:

$248.52M

Gross Profit (TTM)

PAA:

$1.55B

AVDL:

$234.76M

EBITDA (TTM)

PAA:

$2.54B

AVDL:

$10.13M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PAA vs. AVDL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PAA
PAA Risk / Return Rank: 8787
Overall Rank
PAA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
PAA Sortino Ratio Rank: 9090
Sortino Ratio Rank
PAA Omega Ratio Rank: 8787
Omega Ratio Rank
PAA Calmar Ratio Rank: 8383
Calmar Ratio Rank
PAA Martin Ratio Rank: 8585
Martin Ratio Rank

AVDL
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PAA vs. AVDL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Plains All American Pipeline, L.P. (PAA) and Avadel Pharmaceuticals plc (AVDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PAAAVDLDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.38

Calmar ratioReturn relative to maximum drawdown

2.91

Martin ratioReturn relative to average drawdown

8.41

PAA vs. AVDL - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PAAAVDLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.85

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.31

Drawdowns

PAA vs. AVDL - Drawdown Comparison


Loading charts...

Drawdown Indicators


PAAAVDLDifference

Max Drawdown

Largest peak-to-trough decline

-91.99%

Max Drawdown (1Y)

Largest decline over 1 year

-14.53%

Max Drawdown (3Y)

Largest decline over 3 years

-22.26%

Max Drawdown (5Y)

Largest decline over 5 years

-26.11%

Max Drawdown (10Y)

Largest decline over 10 years

-87.92%

Current Drawdown

Current decline from peak

-8.58%

Average Drawdown

Average peak-to-trough decline

-25.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.01%

Volatility

PAA vs. AVDL - Volatility Comparison


Loading charts...

Volatility by Period


PAAAVDLDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.29%

Volatility (6M)

Calculated over the trailing 6-month period

14.05%

Volatility (1Y)

Calculated over the trailing 1-year period

18.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.83%

Dividends

PAA vs. AVDL - Dividend Comparison

PAA's dividend yield for the trailing twelve months is around 7.00%, while AVDL has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AVDL
Avadel Pharmaceuticals plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PAA
Plains All American Pipeline, L.P.
7.00%8.46%7.44%7.06%7.08%7.71%10.92%7.50%5.99%9.45%8.21%11.93%

Financials

PAA vs. AVDL - Financials Comparison

This section allows you to compare key financial metrics between Plains All American Pipeline, L.P. and Avadel Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
12.47B
77.47M
(PAA) Total Revenue
(AVDL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PAA and AVDL have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for PAA and AVDL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer